Profil
Nigel Clark is currently the Senior Vice President-Business Development at Kymab Ltd.
He previously worked as the Vice President-Business Development at Ligand UK Ltd., Co-Head-Biotech Business Unit at Datamonitor Ltd., Head-Business Development at RiboTargets Ltd., and Chief Business Officer at Ipsen Bioinnovation Ltd.
Postes actifs de Nigel Clark
| Sociétés | Poste | Début |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Anciens postes connus de Nigel Clark
| Sociétés | Poste | Fin |
|---|---|---|
Datamonitor Ltd.
 Datamonitor Ltd. Investment ManagersFinance Datamonitor Ltd. is a UK-based investment research firm which was founded by Michael Danson in 1988. The firm is headquartered in London and they are a subsidiary of Informa Group Ltd., which is owned by Informa Plc (LON: INF). Datamonitor provides market research and analysis products and services for the financial services, healthcare, energy, and automotive industrial sectors. | Corporate Officer/Principal | - |
| VERNALIS | Corporate Officer/Principal | - |
| RiboTargets Ltd. | Corporate Officer/Principal | - |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ipsen Bioinnovation Ltd.
Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| RiboTargets Ltd. | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Datamonitor Ltd.
Datamonitor Ltd. Investment ManagersFinance Datamonitor Ltd. is a UK-based investment research firm which was founded by Michael Danson in 1988. The firm is headquartered in London and they are a subsidiary of Informa Group Ltd., which is owned by Informa Plc (LON: INF). Datamonitor provides market research and analysis products and services for the financial services, healthcare, energy, and automotive industrial sectors. | Finance |
